Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 13 Jan 2021 |
2 | Reply to Exam Report (MIS-R) | 11 Feb 2021 |
3 | Documents in support of Show cause Hearing (SCH) | 14 Oct 2022 |
4 | TM-O(NOTICE OF OPPOSITION) | 21 Nov 2022 |
5 | Journal Copy | 13 Dec 2022 |
6 | TM-O(NOTICE OF OPPOSITION) | 28 Feb 2023 |
1 | Hearing Notice (Show Cause) | 14041284 | 06 Sep 2022 | |
2 | Tribunal Accepted Notice for : 4819158 | 14246540 | 5747439 | 20 Oct 2022 |
3 | Opposition Notice | 14819319 | 5866283 | 18 Feb 2023 |
4 | Opposition Notice | 15420137 | 6003526 | 14 Jun 2023 |
5 | Order Form of 21(2) | 15841786 | 6123022 | 16 Aug 2023 |
6 | Order Form of 21(2) | 15841787 | 6122979 | 16 Aug 2023 |
Trademark was applied on 13 January 2021 with IP India.
Proprietor of Amclavin is BLISS GVS PHARMA.
Class(es) in which the trademark was applied to is 5.
Status of Amclavin is Abandoned.
Application number alloted to the trademark is 4819158.
Innovative Consultants is the Trademark agent/attorney.
Trademark has been filed in the following category:
WORD